Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure
NCT ID: NCT04284462
Last Updated: 2020-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
170 participants
INTERVENTIONAL
2020-01-14
2020-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Intervention 1: Control (full sweetness) beverage
* Intervention 2: Step-wise sweetness reduction series of beverages
* Intervention 3: Moderate sweetness (reduced sweetness) beverage
The primary outcome is to assess the perception changes in sweetness (magnitude scale) and sweetness liking (Likert scale) of a test product and a control product over a period of six months. The study endeavors to explore whether consumers of sweetened carbonated beverages can adapt liking to lower sweetness beverages after prolonged exposure of daily consumption of beverages with step-wise reduction of sweetness, or maintenance at reduced (moderate) sweetness.
The secondary outcome will be to assess dietary compensation for sweetness in the step-wise and moderate reduction arms compared to the control arms (the full calorie and low calorie control beverages). Dietary analysis of calories and intakes of total sugar, added sugar, and servings of low-/non-calorie sweeteners will be assessed using a 3-day diet record pre-intervention and monthly for 6 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liking Adaptation to Beverages With Varying Sweetness Levels After Prolonged Exposure
NCT04609657
Liking Adaptation to Beverages of Varying Sweetness Levels Following Prolonged Exposure
NCT05010408
The Effect of Dietary Sugar Consumption on Sweet Taste Perception
NCT02090478
Taste Preferences for Nutritive and Non Nutritive Sweeteners Among Children and Adults
NCT02646956
The Effects of Beverages on Food Liking
NCT03579043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control beverage for Habitual full-calorie CSD cohort, n=28
Full sweetness (sugar) for 6 months
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Control beverage for Habitual low-calorie CSD cohort, n=28
Full sweetness low calorie sweetener (LCS) with sweetness level matched to the full sweetness sugar control for 6 months
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Test beverage 1 for Habitual full-calorie CSD cohort, n=28
Reduced sweetness (moderate sugar level) for 6 months
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Test beverage 1 for Habitual low-calorie CSD cohort, n=28
Reduced sweetness low calorie sweetener (LCS) with sweetness level matched to the moderate sugar sweetness level for 6 months
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Test beverage 2 for Habitual full-calorie CSD cohort, n=28
Step-wise sweetness reduction over 6 months. Month 1 is the full sweetness sugar control, followed by monthly sweetness reduction. Remains at the reduced sweetness level (moderate sugar level) from months 4-6.
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Test beverage 2 for Habitual low-calorie CSD cohort, n=28
Step-wise sweetness reduction over 6 months. Month 1 is the low calorie sweetener (LCS) sweetness equivalent of the full sweetness sugar control, followed by monthly LCS sweetness reduction (reductions equivalent to the corresponding sugar reduction arm sweetness levels). Remains at the reduced sweetness level (LCS equivalent of moderate sugar sweetness level) from months 4-6.
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavored carbonated soft drink (CSD)
1-2 cans/day (330 ml per can)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Habitually consume regular or diet carbonated soft drinks (CSD)
3. Willing and able to consume at least one CSD beverage daily for a total of 6 months and abstain from other sweetened beverages
4. Willing and able to complete questionnaires regarding dietary intake and sensory perception
5. Has internet access via computer, phone or other device and is able to maintain internet access throughout the trial in order to complete daily online questionnaires.
6. Participant is judged to be in good health on the basis of medical history and the general health and lifestyle questionnaire.
7. Participant is willing to maintain his or her habitual diet, smoking habits and physical activity patterns, including habitual use of study approved medications and/or dietary supplements throughout the study period.
8. Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.
Exclusion Criteria
2. History or presence of clinically important endocrine (including type 1 or 2 diabetes mellitus), cardiovascular, pulmonary, biliary, renal, hepatic, pancreatic, or neurologic disorders that, in the opinion of the Clinical Investigator, could interfere with the interpretation of the study results.
3. Extreme dietary habits, including but not limited to vegetarian diets and intentional consumption of a high fiber diet, gluten-free, low-carb, vegan, ketogenic.
4. Extreme changes to physical activity
5. Females who are pregnant, planning to be pregnant during the study period, lactating, or of childbearing potential and unwilling to commit to the use of a medically approved form of contraception throughout the study period.
6. Recent history (within 12 months of screening; Visit 1) of alcohol or substance abuse. Alcohol abuse is defined as \>14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits).
7. Individual has a condition the Clinical Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put the participant at undue risk.
8. Dislike of study product taste
9. Participation in another clinical trial within past 30 days and participation in a PepsiCo clinical trial in the past 6 months.
10. People who have phenylketonuria (low calorie sweetened beverages contain aspartame)
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PepsiCo Global R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Kelley, MD
Role: PRINCIPAL_INVESTIGATOR
Biofortis Innovation Services
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BioFortis Innovation Services
Addison, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEP-1908
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.